Moderna公司总裁近日表示,当前关于疫苗投资领域的指导建议仍存在波动,公司正等待相关指引展现出更明确的稳定性后再做决策。这一表态反映出生物科技企业在疫情后时代对投资风向的审慎评估态度。
Moderna公司总裁近日表示,当前关于疫苗投资领域的指导建议仍存在波动,公司正等待相关指引展现出更明确的稳定性后再做决策。这一表态反映出生物科技企业在疫情后时代对投资风向的审慎评估态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.